Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxenda after laparoscopic adjustable gastric banding for insufficient weight loss
ACTRN12617001613392Phase 4Completed
- Sponsor
- Monash University
- Start
- Jan 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity comparing Saxenda with Placebo (2 arms). Primary endpoint: Total body weight loss. Started Jan 2019; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on ACTRN12617001613392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001613392.